Contribute Try STAT+ Today

Listening to biotech CEOs speak on company conference calls requires a special skill.

I don’t mean merely hearing the words spoken. That’s easy enough, especially since much of what CEOs say can be thrown into two basic verbal buckets. There are straightforward facts (“We reported $50 million in sales during the quarter”) that are just cut and paste from a press release anyone can read.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Everything Adam Feuerstein says is a RED FLAG. DO NOT BELIEVE A WORD THIS LYING STOCK MANIPULATOR SAYS. Mr Feuerstein has cost honest investors untold dollars by publishing “fake news” to discredit small Pharma companies for his own profit or for the profit of those who hired him. Mr Feuerstein should be in the same jail cell as that other lying weasel Martin Shkreli.

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy